Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Hypertriglyceridemia: HELP
Terry A. Jacobson
Based on 8 articles published since 2008
||||
Expertise Level
The expertise of Terry A. Jacobson ranks in the
  • Top 0.26%
  • ... of 12,536 published authors worldwide on Hypertriglyceridemia
  • ... from 2008 through 2019
  • ... based on contributions to 8 articles on the topic.
Graphical view (beta)
Uncounted papers?
Work Locations
Details
Most likely:    Emory University   Contact    
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA, USA. · Pubmed 22894624
2008
  • Office of Health Promotion and Disease Prevention, the Department of Medicine, Emory University, Atlanta, GA 30303, USA. · Pubmed 18541599
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of all articles written by Terry A. Jacobson in 2008-2019 about Hypertriglyceridemia:

  • Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia. 2019
  • Determining triglyceride reductions needed for clinical impact in severe hypertriglyceridemia. 2014
  • A new pure ω-3 eicosapentaenoic acid ethyl ester (AMR101) for the management of hypertriglyceridemia: the MARINE trial. 2012
  • Clinical and economic benefits observed when follow-up triglyceride levels are less than 500 mg/dL in patients with severe hypertriglyceridemia. 2012
  • Hospital use and medical care costs up to 5 years after triglyceride lowering among patients with severe hypertriglyceridemia. 2012
  • Estimating health and economic benefits from using prescription omega-3 fatty acids in patients with severe hypertriglyceridemia. 2011
  • Conclusions and recommendations from the symposium, Beyond Cholesterol: Prevention and Treatment of Coronary Heart Disease with n-3 Fatty Acids. 2008
  • Role of n-3 fatty acids in the treatment of hypertriglyceridemia and cardiovascular disease. 2008
Show List of Full Article Records
Google Searches

Learn more about Terry A. Jacobson using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Emory University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Emory University
2019
  • From Brigham and Women's Hospital Heart and Vascular Center and Harvard Medical School, Boston (D.L.B.) · FACT (French Alliance for Cardiovascular Trials), Département Hospitalo-Universitaire FIRE (Fibrose, Inflammation, and Remodeling), Assistance Publique-Hôpitaux de Paris, Hôpital Bichat, Université Paris-Diderot, INSERM Unité 1148, Paris (P.G.S.) · National Heart and Lung Institute, Imperial College, Royal Brompton Hospital, London (P.G.S.) · the Department of Medicine, University of Maryland School of Medicine, Baltimore (M.M.) · the Utah Lipid Center, Salt Lake City (E.A.B.) · the Office of Health Promotion and Disease Prevention, Department of Medicine, Emory University School of Medicine, Atlanta (T.A.J.) · Amarin Pharma, Bedminster, NJ (S.B.K., R.T.D.J., R.A.J., L.J., C.G.) · Montreal Heart Institute, Université de Montréal, Montreal (J.-C.T.) · and the Department of Medicine, Baylor College of Medicine, and the Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston (C.M.B.). · Pubmed 30415628
2014
  • Clinical Effectiveness and Safety, GlaxoSmithKline, Durham, NC. Electronic address: · US Health Outcomes, GlaxoSmithKline, Philadelphia, Pa. · Health Economics and Outcomes, OptumInsight, Eden Prairie, Minn. · Department of Medicine, Emory University, Atlanta, Ga. · Medicines Discovery & Development, GlaxoSmithKline, Durham, NC. · Clinical Effectiveness and Safety, GlaxoSmithKline, Philadelphia, Pa. · Pubmed 24384100
2012
  • Department of Medicine, Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA, USA. · Pubmed 22894624
2008
  • Office of Health Promotion and Disease Prevention, the Department of Medicine, Emory University, Atlanta, GA 30303, USA. · Pubmed 18541599
6 Other Locations Show
Yearly article counts 100001031002
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.